sports
The PI3K Pathway: How It Works, What Goes Wrong, and Why It Matters
A clear look at the PI3K signaling pathway, its role in cell growth and survival, how mutations drive cancer, and which therapies target it today.
Every article on Detroit Bureau about Targeted Therapy — 7 stories covering it, newest first.
news
Understanding EGFR-Positive Lung Cancer: What the Mutation Means for Treatment
EGFR-positive lung cancer is driven by specific gene mutations. Learn how targeted therapies like osimertinib work, who is tested, and what to expect from treatment.
news
Blueprint Medicine: What the Approach Means for Care and Treatment
Blueprint medicine uses genetic and molecular data to create individualized treatment plans. Learn how this approach works, what conditions it targets, and what to expect from c...
sports
Avastin and Surgery: What Patients Should Know
How Avastin (bevacizumab) interacts with surgery, including timing, risks, and what to discuss with your care team before an operation.
sports
Anti-β-Catenin: What It Is, Role in Cancer, and Research Landscape
Explore anti-β-catenin strategies in cancer biology, including Wnt pathway inhibition, degradation mechanisms, and emerging therapeutic approaches.
culture
EGFR/ALK: Understanding the Interplay in Lung Cancer Diagnosis and Treatment
Explore the roles of EGFR and ALK biomarkers in non-small cell lung cancer, how they guide targeted therapy decisions, and what patients should know about testing and resistance.
community
CDK 4/6 Inhibitors: How They Work, Who Benefits, and What to Expect
A clear look at CDK 4/6 inhibitors, the targeted therapy used in HR-positive breast cancer, covering mechanisms, common regimens, side effects, and practical guidance for patien...
Topic